Research Briefing
Brain tumours
More than 12,000 people in the UK are diagnosed with a brain tumour each year. Find out about survival rates, diagnosis, treatment and research on brain tumours.
-
-
Research Briefing
Ketamine
Ketamine is classified as a class B drug in the UK. Data suggests that ketamine use is increasing and there are concerns about the harms of misuse.
-
Research Briefing
Infected Blood Inquiry: recommendations for recognition, healthcare and patient safety
The Infected Blood Inquiry made recommendations to improve patient care and safety, and strengthen the voice of patients in the healthcare system.
-
Research Briefing
Hormone treatments for children and young people: Clinical trial and consultations
This briefing gives an overview of hormone treatments used to treat gender dysphoria in children and young people and details the government-funded PATHWAYS research programme into the safety and effectiveness of these treatments.
-
Research Briefing
Ehlers-Danlos syndromes
Ehlers-Danlos syndromes are genetic conditions that affect the body’s connective tissues. What is the government doing for people affected by these conditions?
-
Research Briefing
Community pharmacy in England
This briefing provides information on community pharmacy services in England. In particular, it focuses on funding, services, workforce and pharmacy closures.
-
Research Briefing
Pelvic mesh and sodium valproate
Pelvic mesh and sodium valproate are medical products that have harmed patients. The government are considering recommendations to provide redress to patients who have been harmed.
-
Research Briefing
Antimicrobial resistance
Antimicrobial resistance (AMR) is a significant threat to public health. This briefing provides information on the causes and implications of the development and spread of AMR and UK action to address it.
-
Research Briefing
The Medical Training (Prioritisation) Bill 2024-2026
The bill would prioritise UK medical graduates and certain other groups for NHS foundation and speciality training from 2026.
-
Research Briefing
Mental Health Bill [HL] 2024-25: progress of the bill
The Mental Health Bill received Royal Assent on 18 December 2025. This briefing provides an overview of the progress of the bill through the House of Commons.
-
Debate Pack
Debate on the potential merits of equal patient access to tissue freezing for advanced brain cancer treatment, diagnostics and research
A Westminster Hall debate has been scheduled for 9.30 am on 7 January on the potential merits of equal patient access to tissue freezing for advanced brain cancer treatment, diagnostics and research. The debate will be opened by Chris Evans MP.
-
Insight
How are medicines prices set in the UK?
The price of medicines in the UK is influenced by multiple factors, including agreements with the pharmaceutical industry to cap spending on branded medicines.
-
Debate Pack
Comprehensive acquired brain Injury action plan
A debate on a comprehensive acquired brain injury action plan is scheduled to take place in Westminster Hall on Thursday 4 December 2025. The debate was scheduled by the Backbench Business Committee and will be led by Sir John Hayes MP.
-
Research Briefing
NHS staff from overseas: statistics
Around one in five NHS staff in England report a nationality other than British. This briefing has statistics on the nationality of NHS staff for doctors, nurses and other groups, figures on EU nationals, and changes since the Brexit vote.
-
Research Briefing
NHS charges
The briefing provides information on NHS charges and looks at proposed changes to the charging regime.
Total results (page 2 of 13)